SBC logo Authors: Amine Heddad, Andrea Krings, Markus Brameier and Bob MacCallum, Stockholm Bioinformatics Center, Stockholm University, Sweden.

NucPred

Fetching P68875 from www.uniprot.org...

The NucPred score for your sequence is 0.60 (see score help below)

   1  MKKIITLKNLFLIILVYIFSEKKDLRCNVIKGNNIKDDEDKRFHLFYYSH    50
51 NLFKTPETKEKKNKKECFYKNGGIYNLSKEIRMRKDTSVKIKQRTCPFHK 100
101 EGSSFEMGSKNITCFYPIVGKKERKTLDTIIIKKNVTNDHVVSSDMHSNV 150
151 QEKNMILIRNIDKENKNDIQNVEEKIQRDTYENKDYESDDTLIEWFDDNT 200
201 NEENFLLTFLKRCLMKIFSSPKRKKTVVQKKHKSNFFINSSLKYIYMYLT 250
251 PSDSFNLVRRNRNLDEEDMSPRDNFVIDDEEEEEEEEEEEEEEEEEEEEE 300
301 EEEEYDDYVYEESGDETEEQLQEEHQEEVGAESSEESFNDEDEDSVEARD 350
351 GDMIRVDEYYEDQDGDTYDSTIKNEDVDEEVGEEVGEEVGEEVGEEVGEE 400
401 VGEEVGEEVGEEVGEEEGEEVGEGVGEEVGEEEGEEVGEEEGEYVDEKER 450
451 QGEIYPFGDEEEKDEGGESFTYEKSEVDKTDLFKFIEGGEGDDVYKVDGS 500
501 KVLLDDDTISRVSKKHTARDGEYGEYGEAVEDGENVIKIIRSVLQSGALP 550
551 SVGVDELDKIDLSYETTESGDTAVSEDSYDKYASNNTNKEYVCDFTDQLK 600
601 PTESGPKVKKCEVKVNEPLIKVKIICPLKGSVEKLYDNIEYVPKKSPYVV 650
651 LTKEETKLKEKLLSKLIYGLLISPTVNEKENNFKEGVIEFTLPPVVHKAT 700
701 VFYFICDNSKTEDDNKKGNRGIVEVYVEPYGNKINGCAFLDEDEEEEKYG 750
751 NQIEEDEHNEKIKMKTFFTQNIYKKNNIYPCYMKLYSGDIGGILFPKNIK 800
801 STTCFEEMIPYNKEIKWNKENKSLGNLVNNSVVYNKEMNAKYFNVQYVHI 850
851 PTSYKDTLNLFCSIILKEEESNLISTSYLVYVSINEELNFSLFDFYESFV 900
901 PIKKTIQVAQKNVNNKEHDYTCDFTDKLDKTVPSTANGKKLFICRKHLKE 950
951 FDTFTLKCNVNKTQYPNIEIFPKTLKDKKEVLKLDLDIQYQMFSKFFKFN 1000
1001 TQNAKYLNLYPYYLIFPFNHIGKKELKNNPTYKNHKDVKYFEQSSVLSPL 1050
1051 SSADSLGKLLNFLDTQETVCLTEKIRYLNLSINELGSDNNTFSVTFQVPP 1100
1101 YIDIKEPFYFMFGCNNNKGEGNIGIVELLISKQEEKIKGCNFHESKLDYF 1150
1151 NENISSDTHECTLHAYENDIIGFNCLETTHPNEVEVEVEDAEIYLQPENC 1200
1201 FNNVYKGLNSVDITTILKNAQTYNINNKKTPTFLKIPPYNLLEDVEISCQ 1250
1251 CTIKQVVKKIKVIITKNDTVLLKREVQSESTLDDKIYKCEHENFINPRVN 1300
1301 KTFDENVEYTCNIKIENFFNYIQIFCPAKDLGIYKNIQMYYDIVKPTRVP 1350
1351 QFKKFNNEELHKLIPNSEMLHKTKEMLILYNEEKVDLLHFYVFLPIYIKD 1400
1401 IYEFNIVCDNSKTMWKNQLGGKVIYHITVSKREQKVKGCSFDNEHAHMFS 1450
1451 YNKTNVKNCIIDAKPKDLIGFVCPSGTLKLTNCFKDAIVHTNLTNINGIL 1500
1501 YLKNNLANFTYKHQFNYMEIPALMDNDISFKCICVDLKKKKYNVKSPLGP 1550
1551 KVLRALYKKLNIKFDNYVTGTDQNKYLMTYMDLHLSHKRNYLKELFHDLG 1600
1601 KKKPADTDANPESIIESLSINESNESGPFPTGDVDAEHLILEGYDTWESL 1650
1651 YDEQLEEVIYNDIESLELKDIEQYVLQVNLKAPKLMMSAQIHNNRHVCDF 1700
1701 SKNNLIVPESLKKKEELGGNPVNIHCYALLKPLDTLYVKCPTSKDNYEAA 1750
1751 KVNISENDNEYELQVISLIEKRFHNFETLESKKPGNGDVVVHNGVVDTGP 1800
1801 VLDNSTFEKYFKNIKIKPDKFFEKVINEYDDTEEEKDLESILPGAIVSPM 1850
1851 KVLKKKDPFTSYAAFVVPPIVPKDLHFKVECNNTEYKDENQYISGYNGII 1900
1901 HIDISNSNRKINGCDFSTNNSSILTSSVKLVNGETKNCEININNNEVFGI 1950
1951 ICDNETNLDPEKCFHEIYSKDNKTVKKFREVIPNIDIFSLHNSNKKKVAY 2000
2001 AKVPLDYINKLLFSCSCKTSHTNTIGTMKVTLNKDEKEEEDFKTAQGIKH 2050
2051 NNVHLCNFFDNPELTFDNNKIVLCKIDAELFSEVIIQLPIFGTKNVEEGV 2100
2101 QNEEYKKFSLKPSLVFDDNNNDIKVIGKEKNEVSISLALKGVYGNRIFTF 2150
2151 DKNGKKGEGISFFIPPIKQDTDLKFIINETIDNSNIKQRGLIYIFVRKNV 2200
2201 SENSFKLCDFTTGSTSLMELNSQVKEKKCTVKIKKGDIFGLKCPKGFAIF 2250
2251 PQACFSNVLLEYYKSDYEDSEHINYYIHKDKKYNLKPKDVIELMDENFRE 2300
2301 LQNIQQYTGISNITDVLHFKNFNLGNLPLNFKNHYSTAYAKVPDTFNSII 2350
2351 NFSCNCYNPEKHVYGTMQVESDNRNFDNIKKNENVIKNFLLPNIEKYALL 2400
2401 LDDEERQKKIKQQQEEEQQEQILKDQDDRLSRHDDYNKNHTYILYDSNEH 2450
2451 ICDYEKNESLISTLPNDTKKIQKSICKINAKALDVVTIKCPHTKNFTPKD 2500
2501 YFPNSSLITNDKKIVITFDKKNFVTYIDPTKKTFSLKDIYIQSFYGVSLD 2550
2551 HLNQIKKIHEEWDDVHLFYPPHNVLHNVVLNNHIVNLSSALEGVLFMKSK 2600
2601 VTGDETATKKNTTLPTDGVSSILIPPYVKEDITFHLFCGKSTTKKPNKKN 2650
2651 TSLALIHIHISSNRNIIHGCDFLYLENQTNDAISNNNNNSYSIFTHNKNT 2700
2701 ENNLICDISLIPKTVIGIKCPNKKLNPQTCFDEVYYVKQEDVPSKTITAD 2750
2751 KYNTFSKDKIGNILKNAISINNPDEKDNTYTYLILPEKFEEELIDTKKVL 2800
2801 ACTCDNKYIIHMKIEKSTMDKIKIDEKKTIGKDICKYDVTTKVATCEIID 2850
2851 TIDSSVLKEHHTVHYSITLSRWDKLIIKYPTNEKTHFENFFVNPFNLKDK 2900
2901 VLYNYNKPINIEHILPGAITTDIYDTRTKIKQYILRIPPYVHKDIHFSLE 2950
2951 FNNSLSLTKQNQNIIYGNVAKIFIHINQGYKEIHGCDFTGKYSHLFTYSK 3000
3001 KPLPNDDDICNVTIGNNTFSGFACLSHFELKPNNCFSSVYDYNEANKVKK 3050
3051 LFDLSTKVELDHIKQNTSGYTLSYIIFNKESTKLKFSCTCSSNYSNYTIR 3100
3101 ITFDPNYIIPEPQSRAIIKYVDLQDKNFAKYLRKL 3135

Positively and negatively influencing subsequences are coloured according to the following scale:

(non-nuclear) negative ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| positive (nuclear)

with NucPred



If you find NucPred useful, please cite this paper:
NucPred - Predicting Nuclear Localization of Proteins. Brameier M, Krings A, Maccallum RM. Bioinformatics, 2007. PubMed id: 17332022
The authors also look forward to your comments and suggestions.

What does the NucPred score mean?

You have to decide on a NucPred score threshold. Sequences which score greater than or equal to this threshold are predicted to spend some time in the nucleus. Higher thresholds yield fewer predicted nuclear proteins, but these predictions are more accurate (you can have higher confidence in them). The table below gives more details of the performance of NucPred estimated using the sequences it was trained on (by cross-validation). Another benchmark is available in the Bioinformatics 2007 paper.

NucPred score threshold Specificity Sensitivity
see above fraction of proteins predicted to be nuclear that actually are nuclear fraction of true nuclear proteins that are predicted (coverage)
0.10 0.45 0.88
0.20 0.52 0.83
0.30 0.57 0.77
0.40 0.63 0.69
0.50 0.70 0.62
0.60 0.71 0.53
0.70 0.81 0.44
0.80 0.84 0.32
0.90 0.88 0.21
1.00 1.00 0.02

Sequences which score >= 0.8 with NucPred and which are predicted by PredictNLS to contain an NLS have been shown to be 93% correct with a coverage of 16%. (PredictNLS by itself is 87% correct with 26% coverage on the same data.)

Go back to the NucPred Home Page.